1. Multi-component reactions and evolutionary chemistry
2. Recent advances in isocyanide-based multicomponent chemistry
3. Dihydrofolate reductases inhibitors: (a) Gangjee, A.; Adair, O.; Queener, S. F. J. Med. Chem. 1999, 42, 2447–2455; (b) Gangjee, A.; Vasudevan, A.; Queener, S. F. J. Med. Chem. 1996, 39, 1438–1446. Tyrosine kinase inhibitors: (c) Hamby, J. M.; Connolly Cleo, J. C.; Schroeder, M. C.; Winters, R. T.; Showalter, H. D. H.; Panek, R. L.; Major, T. C.; Olsewski, B.; Ryan, M. J.; Dahring, T.; Lu, G. H.; Keiser, J. A.; Aneesa, S. C.; Kraker, A. J.; Slintak, V.; Nelson, J. M.; Fry, D. W.; Bradford, L.; Hallak, H.; Doherty, A. M. J. Med. Chem. 1997, 40, 2296–2303.
4. Pyrido [2, 3-d]pyrimidines and Pyrimido[5′, 4′:5, 6]pyrido[2, 3-d]pyrimidines as New Antiviral Agents: Synthesis and Biological Activity